You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 260 No. 10, September 9, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mumps in the Workplace

Further Evidence of the Changing Epidemiology of a Childhood Vaccine-Preventable Disease

Karen M. Kaplan, MD; David C. Marder, MD, MPH; Stephen L. Cochi, MD; Stephen R. Preblud, MD

JAMA. 1988;260(10):1434-1438.


Abstract

The first documented mumps outbreak in the workplace took place between August and December of 1987, when 119 cases of mumps occurred among employees at three Chicago futures exchanges and their household contacts. Twenty-one patients developed 23 complications, and nine persons were hospitalized. Total direct and indirect economic costs associated with the outbreak were $120 738; the cost per case was $1473. Only three patients had written documentation of mumps immunization. The outbreak is consistent with the recent changing epidemiology of mumps and the increase in reported cases in the adolescent and young adult populations. Mumps vaccine was licensed in 1967. but its distribution was limited until 1977 when the Immunization Practices Advisory Committee of the US Public Health Service recommended it for universal use. As a result, a cohort of adolescents and young adults underimmunized against mumps and underexposed to disease is now entering the work force. Vaccination of susceptible employees could prevent the substantial health impact of mumps.

(JAMA 1988;260:1434-1438)



Author Affiliations

From the Division of Immunization, Center for Prevention Services, Centers for Disease Control, Atlanta (Drs Kaplan, Cochi, and Preblud); and Chicago Department of Health (Dr Marder). Dr Kaplan is now with the Division of Field Services, Epidemiology Program Office, Centers for Disease Control, and is assigned to the Pennsylvania State Department of Health, Harrisburg.


Footnotes

Reprint requests to Technical Information Services, Center for Prevention Services, Centers for Disease Control, Atlanta, GA 30333.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mumps Outbreak in a Highly Vaccinated School Population: Evidence for Large-scale Vaccination Failure
Cheek et al.
Arch Pediatr Adolesc Med 1995;149:774-778.
ABSTRACT  

Varicella Vaccine
Bader
JAMA 1994;271:1744-1745.
ABSTRACT  

Vaccine-Preventable Diseases and Medical Personnel: Ensure the Immunity of All!
MURRAY
Arch Intern Med 1990;150:25-26.
ABSTRACT  

Mumps--United States, 1985-1988
JAMA 1989;261:1702-1708.
 

MUMPS: A GROWING DANGER TO YOUNG ADULTS?
JWatch General 1988;1988:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.